Diabetic retinopathy is the most common microvascular complication of diabetes and along with diabetic macular oedema is the main cause of sight loss in working population in developed countries. Hyperglycaemia is the main risk factor.
The standard methods of treatment are laser treatment and vitrectomy. The new therapeutic possibilities are intravitreal application of corticosteroids and application VEGF blockers.